• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 66 of 100
Mother sleeping with newborn baby on bed
HealthHomeopathic Treatments May Have Led to Deaths in Teething Babies
By Sy MukherjeeOctober 12, 2016
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
LeadershipThis Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again
By Sy MukherjeeOctober 12, 2016
Cancer Consulting Elderly Person
HealthWhy Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today
By Sy MukherjeeOctober 10, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThe FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag
By Sy MukherjeeOctober 7, 2016
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
HealthAlnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
By Sy MukherjeeOctober 6, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
HealthGovernment Health Plans Spent Over $1 Billion on Mylan EpiPens Over 5 Years
By Fortune Editors and Reuters and Michelle TohOctober 6, 2016
CIO, 2 Others To Resign After JPMorgan Chase $2 Billion Trading Error
RetailJPMorgan Is Pulling Chase ATMs from Walgreens Stores
By Reuters and Michelle TohOctober 4, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
HealthSamsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug
By Reuters and Michelle TohOctober 3, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
HealthMore and More Americans Think Prescription Drug Costs Are ‘Unreasonable’
By Chauncey L. AlcornSeptember 29, 2016
U.S. company stock buybacks are down 21 percent in the first seven months of 2016.
HealthWhy Intra-Cellular Therapies’ Stock Got Crushed Today
By Sy MukherjeeSeptember 29, 2016
Shelley Ewalt
RetailTarget Pharmacy Customers Are Not Happy With Their New CVS Pill Bottles
By Madeline FarberSeptember 29, 2016
House Oversight Hearing On Prescription Drug Price Increases
LeadershipMartin Shkreli Is Auctioning Off a Chance to Punch Him in the Face
By Megan McCluskey, TIME and Michelle TohSeptember 28, 2016
This Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
HealthThis Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
By Sy MukherjeeSeptember 26, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health3 Highly Dubious Claims Mylan’s CEO Made to Congress
By Sy MukherjeeSeptember 26, 2016
Can a Pill Fix Your Hearing?
HealthCan a Pill Fix Your Hearing?
By Jennifer AlseverSeptember 26, 2016
1...
  • 64
  • 65
  • 66
  • 67
  • 68
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.